忘忧草crb
He liked
He liked
He liked
THERE IS NO URGENCY FOR RBI TO ACT AHEAD OF THE FED’S NEXT MOVE – COMMERZBANK
Economists at Commerzbznka analyze Indian economic outlook after inflation and growth data. Stable inflation, continued expansion February headline inflation in India held steady at 5.1% YoY. Encouragingly, core inflation, which excludes food and energy, moderated further to 3.3% YoY. Headline infla
He liked
SENSEX SET TO OPEN LOWER, TRACKING GLOBAL MARKETS, GIFT NIFTY FUTURES
India’s Sensex eyes a subdued opening, as Asian stocks trade mixed while Gift Nifty futures drop.Sensex hit fresh record highs above 74,000 last week but finished flat on Thursday.Markets stay cautious ahead of the US and Indian CPI inflation data on Tuesday. The Sensex 30, one of India’s key benchm
He liked
He liked
He liked
He liked
He liked
He liked
He liked
He liked
港股异动 | 康哲药业(00867)涨超4% 美泰彤正式进入规模化临床应用
康哲药业(00867)涨超4%,截至发稿,涨3.51%,报12.96港元,成交额3217.75万港元。 消息面上,近日,康哲药业创新药美泰彤(预充式甲氨蝶呤注射液)在全国多地多家医院开出首张处方,标志着我国目前首个以皮下给药方式治疗银屑病的预充式甲氨蝶呤注射液正式进入临床应用,为银屑病的传统治疗带来全新的优化选择,开启银屑病治疗新时代。 此外,康哲药业已完成美泰彤用于成人类风湿性关节炎(RA)的中国桥接试验全部受试者入组工作。甲氨蝶呤是国际公认治疗RA的一线首选药物和锚定药物,美泰彤有望成为中国首个以皮下给药方式治疗RA的预充式甲氨蝶呤注射液。
He liked
Ekuator Swarna Sekuritas Kena Suspensi BEI Gara-Gara MKBD di Bawah Rp25 Miliar
Ekuator Swarna Sekuritas Kena Suspensi BEI Gara-Gara MKBD di Bawah Rp25 Miliar IDXChannel - Bursa Efek Indonesia (BEI) menghentikan sementara (suspensi) aktivitas perdagangan PT Ekuator Swarna Sekuritas pada hari ini, Kamis (12/10/2023). Dalam pengumuman Nomor Peng-00046/BEI.ANG/10-2023 yang diteken
Pull-up Update